Position in PHVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$49,276,500
-$4,934,402 QoQ
Shares Held
1,425,000
-25.7% QoQ
Ownership
2.03%
of shares outstanding
% of Portfolio
2.96%
of 13F equity value
Holder Rank
#12
of 124 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Commodore Capital LP holds $1,375,688,495 across 28 Biotechnology names. PHVS ranks #12 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RLAY |
Relay Therapeutics, Inc.
|
12,000,000 | $224,520,000 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
3,275,000 | $166,206,250 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
3,050,000 | $118,035,000 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
2,000,000 | $94,080,000 | |
| 5 | SYRE |
Spyre Therapeutics, Inc.
|
846,786 | $75,177,661 | |
| 6 | ANRO |
Alto Neuroscience, Inc.
|
2,723,196 | $71,865,142 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
2,250,000 | $70,335,000 | |
| 8 | EYPT |
EyePoint, Inc.
|
4,600,000 | $65,780,000 |
All Filings in PHVS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,276,500 | 1,425,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $54,210,902 | 1,918,970 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $52,432,098 | 1,889,445 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $60,340,976 | 2,418,476 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $33,641,220 | 1,911,433 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $30,009,498 | 1,911,433 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $36,642,170 | 1,911,433 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $35,399,739 | 1,911,433 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $34,031,290 | 1,810,175 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $39,864,750 | 1,725,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $22,440,000 | 800,000 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||